SpeculatingStocks.com: Stock Picks, Stock Analysis and Stock Updates Daily
Enter your Email Address for Stock Alerts Intraday Stock Updates
SpeculatingStocks.com Homepage Stock Market Services Offered Our Winning Stock Pick Success
Stock Picks
Featured Stock Profiles

Stock Notes
Stock Updates on Past Stock Picks
Speculation Board
Testimonials from Viewers
The SpeculatingStocks.com Team
Contact us and More Info
  

February 8th, 2007

SpeculatingStocks.com Stock Pick: Insmed, Inc. (INSM)

Price: $1.07 (short-term strong buy)

Insmed, Inc. is a biopharmaceutical company focused on the development and commercialization of drugs for the treatment of metabolic diseases and endocrine disorders with unmet medical needs.

INSM holds significant drug assets to treat ALS (Lou Gehrig's disease) and short stature in children due to a growth hormone deficiency. The company is also exploring uses for its Iplex drug in treating insulin resistance, myotonic muscular dystrophy and disorders associated with HIV.

We believe the assets that INSM holds are worth more than the company's current market cap of $107.28 million. The company had $35.27 million in cash and cash equivalents as of their latest balance sheet on September 30, 2006.

INSM experienced strong buying volume yesterday and early morning today. INSM is coming into play as biotech stocks continue to get their fair share of attention.

SpeculatingStocks.com Target Price: We expect INSM to reach $1.60 within the next 1 - 2 months.

Please Read our Legal Disclaimer Our Privacy Policy